Home › NCT05874843

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Who can join

3 Months – 18 Years · All sexes

Inclusion Criteria:

-Patients less than 18 years of age undergoing elective pediatric surgical care in the operating room at Riley Hospital for Children

Exclusion Criteria:

* Known disorder of coagulation pathway(s)
* Administration of medications that may alter the coagulation cascade
* Patients in foster care or wards of the court

About the study

The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.

What is being tested

• Thromboelastography (TEG 6S) (diagnostic test)

Sponsor: Indiana University · Participants: 125 · Started: Sep 11, 2023

Contact the study team

• Matthew Landman, MD, MPH · Phone: 317-944-4681

Official record on ClinicalTrials.gov — NCT05874843

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.